Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Net Income (2019 - 2025)

Silo Pharma (SILO) has disclosed Net Income for 7 consecutive years, with -$881530.0 as the latest value for Q4 2025.

  • Quarterly Net Income rose 49.06% to -$881530.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.2 million through Dec 2025, up 3.76% year-over-year, with the annual reading at -$4.2 million for FY2025, 3.76% up from the prior year.
  • Net Income hit -$881530.0 in Q4 2025 for Silo Pharma, up from -$1.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $230575.0 in Q4 2021 to a low of -$1.8 million in Q1 2023.
  • Historically, Net Income has averaged -$768661.3 across 5 years, with a median of -$928814.0 in 2024.
  • Biggest five-year swings in Net Income: soared 221.92% in 2021 and later tumbled 155772.06% in 2023.
  • Year by year, Net Income stood at $230575.0 in 2021, then crashed by 100.5% to -$1163.0 in 2022, then crashed by 90319.26% to -$1.1 million in 2023, then plummeted by 64.57% to -$1.7 million in 2024, then skyrocketed by 49.06% to -$881530.0 in 2025.
  • Business Quant data shows Net Income for SILO at -$881530.0 in Q4 2025, -$1.1 million in Q3 2025, and -$1.2 million in Q2 2025.